Jump Financial’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-46,200
Closed -$6.01M 2458
2025
Q4
$6.01M Sell
46,200
-46,348
-50% -$6.36M 0.07% 324
2025
Q3
$9.97M Buy
92,548
+82,648
+835% +$9M 0.12% 217
2025
Q2
$914K Sell
9,900
-36,315
-79% -$2.85M 0.01% 1007
2025
Q1
$4.09M Buy
+46,215
New +$4.01M 0.06% 378
2024
Q4
Sell
-7,835
Closed -$333K 2059
2024
Q3
$333K Sell
7,835
-5,765
-42% -$195K 0.01% 1265
2024
Q2
$356K Sell
13,600
-2,224
-14% -$42.1K 0.01% 1302
2024
Q1
$144K Buy
+15,824
New +$95K ﹤0.01% 1752
2023
Q3
Sell
-14,832
Closed -$88.4K 2294
2023
Q2
$88.4K Buy
+14,832
New +$117K ﹤0.01% 1672
2022
Q1
Sell
-5,315
Closed -$782K 1953
2021
Q4
$782K Buy
+5,315
New +$1.19M 0.05% 479

Other funds holding WGS

Jump Financial's WGS Position: Q1 2026 in Review

Jump Financial sold out of GeneDx Holdings (WGS) in Q1 2026, closing a stake of 46,200 shares — an estimated $6.01M sold.

Jump Financial first reported a position in WGS in Q4 2021 and held it in 9 quarters. The position peaked at $9.97M in Q3 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Jump Financial reported no remaining GeneDx Holdings position as of Q1 2026 after selling out during the quarter.
  • Jump Financial sold 46,200 GeneDx Holdings shares in Q1 2026, an estimated $6.01M.
  • Jump Financial first reported a position in GeneDx Holdings in Q4 2021 and held it in 9 quarters.
  • Jump Financial's GeneDx Holdings position peaked at $9.97M in Q3 2025.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.